XML 43 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Dec. 31, 2012
Real estate:    
Buildings and improvements $ 10,623,382 $ 10,537,484
Development costs and construction in progress 223,534 236,864
Land 1,853,392 1,850,397
Accumulated depreciation and amortization (1,822,628) (1,739,718)
Net real estate 10,877,680 10,885,027
Net investment in direct financing leases 6,921,421 6,881,393
Loans receivable, net 291,870 276,030
Investments in and advances to unconsolidated joint ventures 209,810 212,213
Accounts receivable, net of allowance of $1,632 and $1,668, respectively 32,183 34,150
Cash and cash equivalents 47,547 247,673
Restricted cash 37,675 37,848
Intangible assets, net 537,692 552,701
Other assets, net 776,853 788,520
Total assets 19,732,731 [1] 19,915,555 [1]
LIABILITIES AND EQUITY    
Bank line of credit 14,000  
Term loan 208,213 222,694
Senior unsecured notes 6,563,749 6,712,624
Mortgage debt 1,680,792 1,676,544
Other debt 78,836 81,958
Intangible liabilities, net 101,633 105,909
Accounts payable and accrued liabilities 238,583 293,994
Deferred revenue 64,866 68,055
Total liabilities 8,950,672 [2] 9,161,778 [2]
Commitments and contingencies      
Common stock, $1.00 par value: 750,000,000 shares authorized; 454,416,748 and 453,191,321 shares issued and outstanding, respectively 454,417 453,191
Additional paid-in capital 11,218,702 11,180,066
Cumulative dividends in excess of earnings (1,075,249) (1,067,367)
Accumulated other comprehensive loss (16,604) (14,653)
Total stockholders' equity 10,581,266 10,551,237
Joint venture partners 15,185 14,752
Non-managing member unitholders 185,608 187,788
Total noncontrolling interests 200,793 202,540
Total equity 10,782,059 10,753,777
Total liabilities and equity $ 19,732,731 $ 19,915,555
[1] The Company's consolidated total assets at March 31, 2013 and December 31, 2012, include assets of certain variable interest entities ("VIEs") that can only be used to settle the liabilities of those VIEs as follows: accounts receivable, net, $2 million in each period presented; cash and cash equivalents, $10 million in each period presented; and other assets, net, $3 million and $2 million, respectively. See Note 16 to the Condensed Consolidated Financial Statements for additional information.
[2] The Company's consolidated total liabilities at March 31, 2013 and December 31, 2012, include liabilities of certain VIEs for which the VIE creditors do not have recourse to HCP, Inc. as follows: other debt, $0.2 million in each period presented; accounts payable and accrued liabilities, $15 million and $14 million, respectively; and deferred revenue, $2 million in each period presented. See Note 16 to the Condensed Consolidated Financial Statements for additional information.